TSS
SXTC icon

Two Sigma Securities’s China SXT Pharmaceuticals SXTC Stock Holding History

Two Sigma Securities’s Portfolio SXTC Stock Details SXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-103
Closed -$24.3K – 2002
2025
Q3 		$24.3K Buy
+103
New +$25.4K ﹤0.01% 1103
2023
Q4 		– Sell
-2
Closed -$6.15K – 3573
2023
Q3 		$6.15K Buy
2
+1
+100% +$4.94K ﹤0.01% 2767
2023
Q2 		$4.83K Hold
1
– – ﹤0.01% 2669
2023
Q1 		$4.4K Hold
1
– – ﹤0.01% 2535
2022
Q4 		$24.2K Buy
+1
New +$19.2K ﹤0.01% 2252
2022
Q2 		– Hold
0
– -$39K – 2824
2022
Q1 		– Hold
0
– – – 1905
2021
Q4 		– Hold
0
– -$11K – 2022
2021
Q3 		– Hold
0
– – – 1488
2020
Q3 		– Hold
0
– -$10K – 1649
2020
Q2 		– Hold
0
– – – 1313

Other funds holding SXTC

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's SXTC Position: Q4 2025 in Review

Two Sigma Securities sold out of China SXT Pharmaceuticals (SXTC) in Q4 2025, closing a stake of 103 shares — an estimated $24.3K sold.

Two Sigma Securities first reported a position in SXTC in Q4 2022 and held it in 5 quarters. The position peaked at $24.3K in Q3 2025. 8 funds tracked by Wall St. Rank hold SXTC as of Q4 2025.

  • Two Sigma Securities reported no remaining China SXT Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 103 China SXT Pharmaceuticals shares in Q4 2025, an estimated $24.3K.
  • Two Sigma Securities first reported a position in China SXT Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • Two Sigma Securities's China SXT Pharmaceuticals position peaked at $24.3K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.